Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.
Clinical Benefit
| Insufficient |
The actual benefit of LERCAPRESS 10 mg/10 mg is insufficient in view of the available clinical data: this data is insufficient to assess its value for the management of hypertensive patients. |
| Substantial |
|
Clinical Added Value
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
ges49aNfMLhs2tbt
